Please assess the completion status of the following clinical trial:

Trial Title: Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female between 18 and 50 years of age (with onset before age 40)~* Presence of chronic plaque type psoriasis unresponsive to treatment with topical preparations and extensive enough to consider appropriateness of systemic therapy~* Guttate forms of psoriasis~* Non-responsive to treatment or worsening of the pre-existing psoriasis~* With the exception of their skin disease , in good general state of health based on a complete medical history, blood test and urine analysis.~* Females must have negative urine pregnancy test and willing to take additional measures to keep from becoming pregnant during the course of the study~* No systemic prescription medication to control psoriasis within past 30 days~* Free of any topical antipsoriatic preparation for the duration of the study with the exception of emollients and moisturizers~Exclusion Criteria:~* Pustular forms of psoriasis, either localized or generalized~* Generalized Erythrodermic psoriasis~* Only palmoplantar psoriasis~* Only scalp psoriasis~* Only nail psoriasis~* Only inverse psoriasis~* Diabetes or impaired glucose tolerance~* History of recurrent yeast infections~* History of hypersensitivity to Penicillin~* History of severe adverse drug reactions~* Pregnancy~* Lactation~* HIV/AIDS~* History of renal disease~* History of liver disease~* History or presence of alcohol and/or drug dependence or abuse~* History of significant psychiatric illness~* History of allergy, asthma, allergic rhinitis, or urticaria subjects in other research trials, at least 30 days prior to the beginning of this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).